STAT+: Amy Abernethy to step down as Verily’s chief medical officer in latest departure from company
Amy Abernethy, the president of product development and chief medical officer at Verily, told STAT she will leave the company at the end of the first quarter to start a…
Amy Abernethy, the president of product development and chief medical officer at Verily, a health care spinout of search giant Alphabet, will leave the company at the end of the first quarter to start a nonprofit aimed at changing the way the health care system collects data.
The company announced Abernethy’s move to employees on Tuesday.
Both Verily and Abernethy insist the company is well-positioned to move toward her vision — that changing clinical research can speed the development of new products. But from the outside, the move looks like one more sharp jerk for an organization that has spent eight years narrowing its focus and finding its mission.
What's Your Reaction?
